These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3940542)

  • 1. Part of the activating cross-linked immunoglobulin G is internalized by human platelets to sites not accessible for enzymatic digestion.
    Spycher MO; Nydegger UE
    Blood; 1986 Jan; 67(1):12-8. PubMed ID: 3940542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of the mechanism of the human platelet release reaction induced by immunologic stimuli. III. Relationship between the binding of soluble IgG aggregates to the Fc receptor and cell response in the presence and absence of plasma.
    Pfueller SL; Weber S; Lüscher EF
    J Immunol; 1977 Feb; 118(2):514-24. PubMed ID: 557068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Binding of IgG and its aggregates to human platelets can be made saturable by using deoxyglucose and antimycin A].
    Spycher MO; Gross B; Nydegger UE
    Schweiz Med Wochenschr; 1983 Oct; 113(40):1469-71. PubMed ID: 6648428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histidine-rich glycoprotein binding to activated human platelets.
    Lerch PG; Nydegger UE; Kuyas C; Haeberli A
    Br J Haematol; 1988 Oct; 70(2):219-24. PubMed ID: 3191032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibronectin-mediated inhibition of human platelet activation by crosslinked immunoglobulin G.
    Spycher MO; Lerch PG; Nydegger UE
    Br J Haematol; 1986 Oct; 64(2):299-307. PubMed ID: 2946316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of internalization in platelet activation induced by collagen fibers--differential effects of aspirin, cytochalasin D, and prostaglandin E1.
    Ruf A; Patscheke H; Morgenstern E
    Thromb Haemost; 1991 Dec; 66(6):708-14. PubMed ID: 1796416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic susceptibility of platelet low density lipoprotein receptor.
    Pedreño J; Fernández R
    Lipids; 1995 Oct; 30(10):927-33. PubMed ID: 8538380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liberation of surface and internal platelet-associated IgG (PA-IgG) during platelet activation.
    Pfueller SL; David R
    Br J Haematol; 1986 Aug; 63(4):785-94. PubMed ID: 3730298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein.
    Roth GJ; Majerus PW
    J Clin Invest; 1975 Sep; 56(3):624-32. PubMed ID: 1159076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of ADP-induced platelet responses by covalent modification of aggregin, a putative ADP receptor, by 8-(4-bromo-2,3-dioxobutylthio)ADP.
    Puri RN; Kumar A; Chen H; Colman RF; Colman RW
    J Biol Chem; 1995 Oct; 270(41):24482-8. PubMed ID: 7592664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nitrovasodilators on platelet cyclic nucleotide levels in rabbit blood; role for cyclic AMP in synergistic inhibition of platelet function by SIN-1 and prostaglandin E1.
    Bowen R; Haslam RJ
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):424-33. PubMed ID: 1711604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet IgG Fc receptor.
    Kelton JG; Smith JW; Santos AV; Murphy WG; Horsewood P
    Am J Hematol; 1987 Jul; 25(3):299-310. PubMed ID: 3605076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the effect of modification of the surface of human platelets on the receptors for aggregated immunoglobulins and for ristocentin-von Willebrand factor.
    Pfueller SL; Jenkins CS; Lüscher EF
    Biochim Biophys Acta; 1977 Mar; 465(3):614-26. PubMed ID: 319830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cationized ferritin as a platelet-stimulating surface probe. Binding to platelets and effects on platelet function.
    Patscheke H; Dierichs R
    Eur J Cell Biol; 1986 Mar; 40(1):64-71. PubMed ID: 3084260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internalization and down-regulation of the prostacyclin receptor in human platelets.
    Giovanazzi S; Accomazzo MR; Letari O; Oliva D; Nicosia S
    Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):71-7. PubMed ID: 9224631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the Fc gamma receptor on human platelets.
    King M; McDermott P; Schreiber AD
    Cell Immunol; 1990 Jul; 128(2):462-79. PubMed ID: 2141549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
    Williams KA; Murphy W; Haslam RJ
    Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of serotonin from human platelets induced by aggregated immunoglobulins of different classes and subclasses.
    Henson PM; Spiegelberg HL
    J Clin Invest; 1973 May; 52(5):1282-8. PubMed ID: 4700496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet interactions with C1q in whole blood and in the presence of immune complexes or aggregated IgG.
    Peerschke EI; Ghebrehiwet B
    Clin Immunol Immunopathol; 1992 Apr; 63(1):45-50. PubMed ID: 1591882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monomeric IgG preparations for intravenous use inhibit platelet stimulation by polymeric IgG.
    Gross B; Haessig A; Luescher EF; Nydegger UE
    Br J Haematol; 1983 Feb; 53(2):289-99. PubMed ID: 6401428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.